US2020291461A1PendingUtilityA1

Novel methods and compositions to evaluate and determine inactivation of hazardous biological material

Assignee: US AGRICULTUREPriority: Sep 11, 2013Filed: Apr 24, 2020Published: Sep 17, 2020
Est. expirySep 11, 2033(~7.1 yrs left)· nominal 20-yr term from priority
C12Q 1/6888C12Q 2600/158C12Q 1/689
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel time and temperature integrator (TTI) assays, kits containing the components of the assays, and the novel components for those assays are provided herein. These novel TTI assays evaluate and/or determine the inactivation of biological material in/on a sample by quantifying the degradation of DNA using qPCR. The sample can be a food product (e.g., fruits, vegetables, meat from animals, or eggs) while the item can be any object (e.g., medical equipment, especially reusable medical equipment) for which one needs to determine that the amount of inactivation of specific hazardous biological material on the object or in a sample is at or below a pre-determined amount.

Claims

exact text as granted — not AI-modified
We, the inventors, claim: 
     
         1 . A kit comprising:
 a pair of primers comprising a first polynucleotide and a second polynucleotide;   a label;   optionally DNase; and   optionally instructions on using said first polynucleotide and said second polynucleotide in a method to determine the amount of inactivation of a biological material,   wherein said first polynucleotide has the sequence in one of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, and SEQ ID NO: 7, and   wherein when said first polynucleotide has the sequence in SEQ ID NO: 1, said second polynucleotide has the sequence in SEQ ID NO: 2; when said first polynucleotide has the sequence in SEQ ID NO: 3, said second polynucleotide has the sequence in SEQ ID NO: 4; when said first polynucleotide has the sequence in SEQ ID NO: 5, then said second polynucleotide has the sequence in SEQ ID NO: 6; and when said first polynucleotide has the sequence in SEQ ID NO: 7, then said second polynucleotide has the sequence in SEQ ID NO: 8.   
     
     
         2 . The kit of  claim 1  wherein said label is selected from the group consisting of a fluorescent composition, an intercalating dye, a spectroscopic label, a photochemical label, a biochemical label, an immunochemical label, and a chemical label. 
     
     
         3 . The kit of  claim 1  wherein said label comprises:
 a probe; 
 a quencher dye; and 
 a fluorescent dye, 
 wherein said quencher dye and said fluorescent dye are linked to said probe, 
 wherein when the sequence of said first polynucleotide is SEQ ID NO: 1, said probe has a sequence of between approximately 15 contiguous bases and approximately 45 contiguous bases of SEQ ID NO: 14 or the reverse complement thereof, 
 wherein when the sequence of said first polynucleotide is SEQ ID NO: 3, said probe has a sequence of between approximately 15 contiguous bases and approximately 45 contiguous bases of SEQ ID NO: 15 or the reverse complement thereof, 
 wherein when the sequence of said first polynucleotide is SEQ ID NO: 5, said probe has a sequence of between approximately 15 contiguous bases and approximately 45 contiguous bases of SEQ ID NO: 16 or the reverse complement thereof, and 
 wherein when the sequence of said first polynucleotide is SEQ ID NO: 7, said probe has a sequence of between approximately 15 contiguous bases and approximately 45 contiguous bases of SEQ ID NO: 17 or the reverse complement thereof. 
 
     
     
         4 . A kit comprising:
 a pair of primers comprising a first polynucleotide and a second polynucleotide;   a label;   optionally DNase; and   instructions on using said first polynucleotide and said second polynucleotide in a method to determine the amount of inactivation of a biological material,   wherein said first polynucleotide has the sequence in one of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, and SEQ ID NO: 7, and   wherein when said first polynucleotide has the sequence in SEQ ID NO: 1, said second polynucleotide has the sequence in SEQ ID NO: 2; when said first polynucleotide has the sequence in SEQ ID NO: 3, said second polynucleotide has the sequence in SEQ ID NO: 4; when said first polynucleotide has the sequence in SEQ ID NO: 5, then said second polynucleotide has the sequence in SEQ ID NO: 6; and when said first polynucleotide has the sequence in SEQ ID NO: 7, then said second polynucleotide has the sequence in SEQ ID NO: 8.

Join the waitlist — get patent alerts

Track US2020291461A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.